Hong Kong News

Nonpartisan, Noncommercial, unconstrained.
Monday, May 17, 2021

Johnson & Johnson vaccine delayed in Europe due to safety concerns

Johnson and Johnson has delayed the rollout of its Covid vaccine in Europe after regulators in the United States called for a pause because of safety concerns.
The vaccine is marketed under the brand name Janssen in Europe.

Six people who'd had the vaccine in the US have developed rare and severe blood clots. It's so far been given to around seven million Americans.
Newsletter

Quote of the Day

Believe those who are seeking the truth. Doubt those who find it.

André Gide
Related Articles

Hong Kong News
×